Kidney Cancer Diagnostics And Therapeutics Market – U.S. Food and Drug Administration approved Sutent

Posted April 15, 2019 by OliveDavid

Kidney Cancer Diagnostics and Therapeutics Market worth was $3.47 billion in 2018, and it was estimated to reach at a CAGR of 5.64%, to reach $4.57 billion by 2023.

Recent Developments

Kidney cancer is one of the repeated urologic tumors, which accounted for around 3% of all human cancers. The frequency rate of renal cell carcinoma has raised progressively in the current decades.

On November 2017 - The U.S. Food and Drug Administration granted Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at high danger of kidney cancer returning after a kidney removed (nephrectomy).

To know more, read @

Market Overview

Market Data Forecast published a report named Kidney Cancer Diagnostics and Therapeutics Market. The Global Kidney Cancer Diagnostics and Therapeutics Market worth was $3.47 billion in 2018, and it was estimated to reach at a CAGR of 5.64%, to reach $4.57 billion by 2023.

Report segmented as:

By Type:

Transitional Cell Cancer
Renal Cell Carcinoma
Renal Sarcoma
By Tests:

CT Scan
Intravenous Pyelogram
Kidney Ultrasound
Factors such as raised R&D spending of pharmaceutical companies and rising incidences of chronic diseases and the elderly population will lead to the development of the market in the forecast period.

Geographical Segmentation:

Based on geography, the market divided under many countries namely, North America, Asia-Pacific, Europe, Latin America and the Middle East and Africa. North America has led the Kidney Cancer Diagnostics, and Therapeutics Market and Asia-Pacific estimated to reach the highest rate.

Key market players:

Sanofi S.A
Abbott Laboratories
Hoffmann La Roche
Seattle Genetics
Cerulean Pharma
View a sample and decide @

The Scope of the report:

The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed, and the prospects with huge growth potential identified and debated.

The key players in the industry are profiled giving insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry had provided. The report also provides a broad outlook of the current market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: [email protected]

Tel: +1-888-702-9626

-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Data Forecast
Phone 18887029626
Business Address UNITED STATES
Country Philippines
Categories Medical
Last Updated April 15, 2019